SCHEMBL4598889

SCHEMBL4598889

Cc1ccc(S(=O)(=O)Oc2cccc(OC(=O)N3CCOCC3)c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
HSD17B10 Q99714 1/20 0.58
KMT2A Q03164 2/20 0.56
ATM Q13315 1/20 0.56
EPHX1 P07099 2/20 0.55
NPSR1 Q6W5P4 2/20 0.54
MEN1 O00255 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.50
TSHR P16473 2/20 0.50
GAA P10253 2/20 0.49
ALDH1A1 P00352 1/20 0.49
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599586 0.90 HSD17B10 (0.69) HSD17B10KMT2AATMEPHX1NPSR1
SCHEMBL4599457 0.83 HSD17B10 (0.66) CYP1A2CYP2C9CYP2C19HSD17B10KMT2A
SCHEMBL8247308 0.77 CYP1A2 (1.00) CYP1A2CYP2C9CYP2C19KMT2AEPHX1
SCHEMBL26672168 0.73 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19HSD17B10KMT2A
SCHEMBL2298443 0.73 CYP2C9 (0.46) CYP1A2CYP2C9CYP2C19KMT2AATM
SCHEMBL2291605 0.73 CYP2C9 (0.46) CYP1A2CYP2C9CYP2C19KMT2AATM
SCHEMBL4598628 0.72 EPHX1 (0.68) CYP1A2CYP2C9CYP2C19HSD17B10KMT2A
SCHEMBL4599565 0.72 EPHX1 (0.68) CYP1A2CYP2C9CYP2C19HSD17B10KMT2A
SCHEMBL4599459 0.72 EPHX1 (0.68) CYP1A2CYP2C9CYP2C19HSD17B10KMT2A
SCHEMBL28372646 0.72 EPHX1 (0.68) CYP1A2CYP2C9CYP2C19HSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed